Cargando…
Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening?
Fecal microbiota transplantation (FMT) has been reported to decrease the incidence of recurrent urinary tract infections (UTIs), presumably by restoring microbiome diversity and/or uropathogen competition. We report a 16-year-old female with recurrent UTIs caused by multidrug-resistant Klebsiella pn...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314704/ https://www.ncbi.nlm.nih.gov/pubmed/35899275 http://dx.doi.org/10.1093/ofid/ofac324 |
_version_ | 1784754381181157376 |
---|---|
author | Vendrik, Karuna E W de Meij, Tim G J Bökenkamp, Arend Ooijevaar, Rogier E Groenewegen, Bas Hendrickx, Antoni P A Terveer, Elisabeth M Kuijper, Ed J van Prehn, Joffrey |
author_facet | Vendrik, Karuna E W de Meij, Tim G J Bökenkamp, Arend Ooijevaar, Rogier E Groenewegen, Bas Hendrickx, Antoni P A Terveer, Elisabeth M Kuijper, Ed J van Prehn, Joffrey |
author_sort | Vendrik, Karuna E W |
collection | PubMed |
description | Fecal microbiota transplantation (FMT) has been reported to decrease the incidence of recurrent urinary tract infections (UTIs), presumably by restoring microbiome diversity and/or uropathogen competition. We report a 16-year-old female with recurrent UTIs caused by multidrug-resistant Klebsiella pneumoniae, for which frequent intravenous broad-spectrum antibiotic treatment was necessary. The patient was treated with FMT from a well-screened healthy donor without multidrug-resistant bacteria in the feces. After FMT, she developed several UTIs with an antibiotic-susceptible Escherichia coli that could be treated orally. The uropathogenic E. coli could be cultured from donor feces, and whole genome sequencing confirmed donor-to-recipient transmission. Our observation should stimulate discussion on long-term follow-up of all infections after FMT and donor fecal screening for antibiotic-susceptible Enterobacterales. |
format | Online Article Text |
id | pubmed-9314704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-93147042022-07-26 Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening? Vendrik, Karuna E W de Meij, Tim G J Bökenkamp, Arend Ooijevaar, Rogier E Groenewegen, Bas Hendrickx, Antoni P A Terveer, Elisabeth M Kuijper, Ed J van Prehn, Joffrey Open Forum Infect Dis Novel ID Cases Fecal microbiota transplantation (FMT) has been reported to decrease the incidence of recurrent urinary tract infections (UTIs), presumably by restoring microbiome diversity and/or uropathogen competition. We report a 16-year-old female with recurrent UTIs caused by multidrug-resistant Klebsiella pneumoniae, for which frequent intravenous broad-spectrum antibiotic treatment was necessary. The patient was treated with FMT from a well-screened healthy donor without multidrug-resistant bacteria in the feces. After FMT, she developed several UTIs with an antibiotic-susceptible Escherichia coli that could be treated orally. The uropathogenic E. coli could be cultured from donor feces, and whole genome sequencing confirmed donor-to-recipient transmission. Our observation should stimulate discussion on long-term follow-up of all infections after FMT and donor fecal screening for antibiotic-susceptible Enterobacterales. Oxford University Press 2022-06-29 /pmc/articles/PMC9314704/ /pubmed/35899275 http://dx.doi.org/10.1093/ofid/ofac324 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Novel ID Cases Vendrik, Karuna E W de Meij, Tim G J Bökenkamp, Arend Ooijevaar, Rogier E Groenewegen, Bas Hendrickx, Antoni P A Terveer, Elisabeth M Kuijper, Ed J van Prehn, Joffrey Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening? |
title | Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening? |
title_full | Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening? |
title_fullStr | Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening? |
title_full_unstemmed | Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening? |
title_short | Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening? |
title_sort | transmission of antibiotic-susceptible escherichia coli causing urinary tract infections in a fecal microbiota transplantation recipient: consequences for donor screening? |
topic | Novel ID Cases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314704/ https://www.ncbi.nlm.nih.gov/pubmed/35899275 http://dx.doi.org/10.1093/ofid/ofac324 |
work_keys_str_mv | AT vendrikkarunaew transmissionofantibioticsusceptibleescherichiacolicausingurinarytractinfectionsinafecalmicrobiotatransplantationrecipientconsequencesfordonorscreening AT demeijtimgj transmissionofantibioticsusceptibleescherichiacolicausingurinarytractinfectionsinafecalmicrobiotatransplantationrecipientconsequencesfordonorscreening AT bokenkamparend transmissionofantibioticsusceptibleescherichiacolicausingurinarytractinfectionsinafecalmicrobiotatransplantationrecipientconsequencesfordonorscreening AT ooijevaarrogiere transmissionofantibioticsusceptibleescherichiacolicausingurinarytractinfectionsinafecalmicrobiotatransplantationrecipientconsequencesfordonorscreening AT groenewegenbas transmissionofantibioticsusceptibleescherichiacolicausingurinarytractinfectionsinafecalmicrobiotatransplantationrecipientconsequencesfordonorscreening AT hendrickxantonipa transmissionofantibioticsusceptibleescherichiacolicausingurinarytractinfectionsinafecalmicrobiotatransplantationrecipientconsequencesfordonorscreening AT terveerelisabethm transmissionofantibioticsusceptibleescherichiacolicausingurinarytractinfectionsinafecalmicrobiotatransplantationrecipientconsequencesfordonorscreening AT kuijperedj transmissionofantibioticsusceptibleescherichiacolicausingurinarytractinfectionsinafecalmicrobiotatransplantationrecipientconsequencesfordonorscreening AT vanprehnjoffrey transmissionofantibioticsusceptibleescherichiacolicausingurinarytractinfectionsinafecalmicrobiotatransplantationrecipientconsequencesfordonorscreening |